NCT07446881

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

A Phase 1, Randomized, Controlled, Latin-square, Open-label Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Advicenne Pharma · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This was a Phase 1, single-center, randomized, controlled, Latin-square, open-label study to evaluate the effect of ADV7103 on the gastric pH, after administering a single oral dose of ADV7103 in healthy adult participants under fasting and fed conditions

Conditions

• EFFECT OF ADV7103 ON GASTRIC PH
• Distal Renal Tublular Acidosis

Interventions

Type	Name	Description
DRUG	ADV7103	EFFECT ON GASTRIC PH

Timeline

• Start date: 2025-02-25
• Primary completion: 2025-03-15
• Completion: 2025-03-15
• First posted: 2026-03-03
• Last updated: 2026-03-10

Locations

1 site across 1 country: France

Regulatory

• FDA-regulated drug study